These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 35957916)

  • 21. Expression of
    Zhang X; Nie X; Long J; Yu J; Zhang P; Liu Y; Wu X; Bai Y; Mao J; Liu X; Yuan Y; Zhao H; Li L
    Ann Transl Med; 2020 Jul; 8(13):819. PubMed ID: 32793664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker.
    Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J
    Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650
    [No Abstract]   [Full Text] [Related]  

  • 23. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
    Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
    Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
    Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
    Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Exploring the Role of PCDHGB4 in the Occurrence of Lung Squamous Cell Carcinoma Based on Bioinformatics Analysis].
    Lu R; Abuduhailili X; Li Y; Ning J; Feng Y
    Zhongguo Fei Ai Za Zhi; 2024 Mar; 27(3):199-215. PubMed ID: 38590195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WNT ligands in non-small cell lung cancer: from pathogenesis to clinical practice.
    Xue W; Cai L; Li S; Hou Y; Wang YD; Yang D; Xia Y; Nie X
    Discov Oncol; 2023 Jul; 14(1):136. PubMed ID: 37486552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
    Wei Q; Miao T; Zhang P; Jiang B; Yan H
    Front Genet; 2022; 13():984575. PubMed ID: 36159963
    [No Abstract]   [Full Text] [Related]  

  • 30. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
    Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
    BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative bioinformatics analysis the clinical value of KMT5A in different subtypes of lung cancer.
    Liu S; Tian W; Li B
    Comput Biol Chem; 2022 Feb; 96():107603. PubMed ID: 34894606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ; Liu SS; Li BR
    Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
    Yin D; Zhang Y; Li H; Cheng L
    Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
    Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
    Hou G; Lu Z; Bi Y; Deng J; Yang X
    Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers.
    Huang Y; Guo DM; Bu S; Xu W; Cai QC; Xu J; Jiang YQ; Teng F
    Adv Ther; 2023 May; 40(5):2186-2204. PubMed ID: 36892810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment.
    Song L; Wang X; Cheng W; Wu Y; Liu M; Liu R; Zhang S; Xia H; Liu H; Tai X; Zhao H; Li X; Ji F
    BMC Pulm Med; 2021 Dec; 21(1):420. PubMed ID: 34923982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced Glycation End Products' Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Yang J; Lin M; Zhang M; Wang Z; Lin H; Yu Y; Zheng Q; Chen X; Wu Y; Yao Q; Li J
    Genet Res (Camb); 2023; 2023():7129325. PubMed ID: 37497166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC).
    Zhang L; Chen J; Cheng T; Yang H; Li H; Pan C
    J Cancer; 2020; 11(17):4965-4979. PubMed ID: 32742444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.